INNOVATIVE PHARMACEUTICAL BIOTECH L financial statements, including revenue, expenses, profit, and loss

The total revenue of 399 for the last semiannual is 3.03 M HKD, and it's 5.69% higher compared to the previous semiannual. The net income of H1 24 is 101.74 M HKD.